These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28571545)

  • 21. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
    Barakat W; Safwet N; El-Maraghy NN; Zakaria MN
    Eur J Pharmacol; 2014 Feb; 724():43-50. PubMed ID: 24378346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
    Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
    World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptors in cerebral ischemic inflammatory injury.
    Wang YC; Lin S; Yang QW
    J Neuroinflammation; 2011 Oct; 8():134. PubMed ID: 21982558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LLDT-8 protects against cerebral ischemia/reperfusion injury by suppressing post-stroke inflammation.
    Chen Y; Zhang L; Ni J; Wang X; Cheng J; Li Y; Zhen X; Cao T; Jia J
    J Pharmacol Sci; 2016 Jun; 131(2):131-7. PubMed ID: 27286958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of drugs acting on the TLRs/MyD88 signaling pathway on colitis-associated cancer.
    Zhu M; Yu K; Wang L; Yu S
    Pharmazie; 2018 Jul; 73(7):363-368. PubMed ID: 30001768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 9: a new target of ischemic preconditioning in the brain.
    Stevens SL; Ciesielski TM; Marsh BJ; Yang T; Homen DS; Boule JL; Lessov NS; Simon RP; Stenzel-Poore MP
    J Cereb Blood Flow Metab; 2008 May; 28(5):1040-7. PubMed ID: 18183029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological role of Toll-like receptor signaling in cerebral malaria.
    Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
    Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2/4.
    Tajalli-Nezhad S; Karimian M; Beyer C; Atlasi MA; Azami Tameh A
    Cell Mol Life Sci; 2019 Feb; 76(3):523-537. PubMed ID: 30377701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.
    Lok KZ; Basta M; Manzanero S; Arumugam TV
    J Neuroinflammation; 2015 Apr; 12():73. PubMed ID: 25886362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice.
    Li L; Zhang X; Cui L; Wang L; Liu H; Ji H; Du Y
    Brain Res; 2013 Feb; 1497():32-9. PubMed ID: 23276496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adaptor protein MyD88 in TLR-mediated preconditioning and neuroprotection after acute excitotoxicity.
    Larochelle A; Bellavance MA; Rivest S
    Brain Behav Immun; 2015 May; 46():221-31. PubMed ID: 25733102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor signaling in endogenous neuroprotection and stroke.
    Marsh BJ; Williams-Karnesky RL; Stenzel-Poore MP
    Neuroscience; 2009 Feb; 158(3):1007-20. PubMed ID: 18809468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daphnetin Protects against Cerebral Ischemia/Reperfusion Injury in Mice via Inhibition of TLR4/NF-
    Liu J; Chen Q; Jian Z; Xiong X; Shao L; Jin T; Zhu X; Wang L
    Biomed Res Int; 2016; 2016():2816056. PubMed ID: 28119924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.
    Chao W
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H1-12. PubMed ID: 19011041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of the TRIF-dependent signaling pathway of Toll-like receptor by CDr10b in RAW264.7 macrophages.
    Gu GJ; Ahn SI; Kim JS; Hong CY; Lee SC; Chang YT; Choi TH; Kim BS; Youn HS
    Int Immunopharmacol; 2015 Sep; 28(1):29-33. PubMed ID: 26004315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.